Home › Funds › Boxer Capital Management, LLC › CYTK

Boxer Capital Management, LLC position in CYTK

CYTOKINETICS INC · Health Care

Boxer Capital Management, LLC reported holding 100,000 shares of CYTK (CYTOKINETICS INC) in its Q2 2026 13F filing — a position valued at US$8.5M, representing 0.64% of its reported portfolio and ranking #29 among its reported holdings. Boxer Capital Management, LLC has disclosed CYTK holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)100.00K sh
Reported value held$8.52M
Portfolio Weight0.64%
First reportedQ3 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Boxer Capital Management, LLC's CYTK position evolved

Boxer Capital Management, LLC first disclosed a stake in CYTK in Q3 2025 at 200,000 shares (US$11.0M). Across 4 filings, Boxer Capital Management, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 100,000 shares valued at US$8.5M. Notable position changes include a 50% trim in Q4 2025 (shares rose 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 200.00K $10.99M New
Q4 2025 100.00K $6.35M Reduce
Q1 2026 100.00K $6.59M Hold
Q2 2026 100.00K $8.52M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CYTK and 13F data

CYTK (CYTOKINETICS INC) is a Health Care company. 52 other funds we track also report a position in CYTK — the largest reported positions include T. Rowe Price Investment Management, Inc. (US$1.59B), Avoro Capital Advisors LLC (US$425.9M), RTW INVESTMENTS, LP (US$243.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CYTK

All CYTK fund holders →

FAQ

How long has Boxer Capital Management, LLC held CYTK?

Boxer Capital Management, LLC has disclosed CYTK holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is Boxer Capital Management, LLC's current position in CYTK?

As of Q2 2026, Boxer Capital Management, LLC holds 100.00K shares of CYTK (CYTOKINETICS INC), valued at $8.52M, representing 0.64% of its reported portfolio and ranking #29.

Has Boxer Capital Management, LLC been buying or selling CYTK?

In the latest 13F filing (Q2 2026), Boxer Capital Management, LLC held unchanged its position in CYTK.

Which other funds hold CYTK?

Other major institutional holders of CYTK include T. Rowe Price Investment Management, Inc., Avoro Capital Advisors LLC, RTW INVESTMENTS, LP, among 52 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.